All lobbying filings
Mr. Brian Kelly
Mr. Brian Kelly filed a Q3 report for Takeda Pharmaceutical Company on October 16, 2025, reporting $10,000 in lobbying income.
Lobbying for Takeda Pharmaceutical Company · Pharmaceuticals
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Government bodies contacted
5
Lobbying activity
4
Trade and tariffs
Government tariffs on drug imporatation.
Trade/Tariffs on drug pricing and importation
tax issues related to drugs and pricing